Terms: = Colorectal cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
23 results:
1. liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon cancer.
Wang P; Zhong W; Huang Q; Zhu Y; Chen L; Ye K
ACS Biomater Sci Eng; 2024 May; 10(5):3136-3147. PubMed ID: 38663028
[TBL] [Abstract] [Full Text] [Related]
2. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.
Wang D; Nakayama M; Hong CP; Oshima H; Oshima M
Cancer Res; 2024 Jan; 84(1):56-68. PubMed ID: 37851521
[TBL] [Abstract] [Full Text] [Related]
3. CCDC144NL-AS1/hsa-miR-143-3p/hmga2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision.
Abd El Fattah YK; Abulsoud AI; AbdelHamid SG; AbdelHalim S; Hamdy NM
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126739. PubMed ID: 37690651
[TBL] [Abstract] [Full Text] [Related]
4. Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress.
He S; Xia J; Jia H; Dai Q; Chen C; Zhou Y; Wang XB
Int Immunopharmacol; 2023 Oct; 123():110753. PubMed ID: 37572505
[TBL] [Abstract] [Full Text] [Related]
5. TGM2, hmga2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
Cheraghi-Shavi T; Jalal R; Minuchehr Z
PLoS One; 2023; 18(8):e0289535. PubMed ID: 37535601
[TBL] [Abstract] [Full Text] [Related]
6. Lactoferrin-Modified Gambogic Acid liposomes for colorectal cancer treatment.
Wang R; Qu J; Tang X; Zhang J; Ou A; Li Q; Chen G; Zheng C; Muhitdinov B; Huang Y
Mol Pharm; 2023 Aug; 20(8):3925-3936. PubMed ID: 37505210
[TBL] [Abstract] [Full Text] [Related]
7. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
[TBL] [Abstract] [Full Text] [Related]
8. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene hmga2 that facilitates colon cancer proliferation and metastasis.
Liu HH; Lee CH; Hsieh YC; Hsu DW; Cho EC
Biochem Biophys Res Commun; 2021 Aug; 567():183-189. PubMed ID: 34166916
[TBL] [Abstract] [Full Text] [Related]
9. A KLF4/PiHL/EZH2/hmga2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer.
Deng X; Kong F; Li S; Jiang H; Dong L; Xu X; Zhang X; Yuan H; Xu Y; Chu Y; Peng H; Guan M
Cell Death Dis; 2021 May; 12(5):485. PubMed ID: 33986248
[TBL] [Abstract] [Full Text] [Related]
10. Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.
Xu L; Zhang Z; Ding Y; Wang L; Cheng Y; Meng L; Wu J; Yuan A; Hu Y; Zhu Y
Biomater Sci; 2019 Nov; 7(11):4782-4789. PubMed ID: 31524211
[TBL] [Abstract] [Full Text] [Related]
11. Anti-colorectal cancer Effect via Application of Polyethylene Glycol Modified liposomal Apatinib.
Hu Y; Zhou P; Lin Y; Yang D; Wang B
J Biomed Nanotechnol; 2019 Jun; 15(6):1256-1266. PubMed ID: 31072433
[TBL] [Abstract] [Full Text] [Related]
12. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through hmga2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract] [Full Text] [Related]
13. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and hmga2.
Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
[TBL] [Abstract] [Full Text] [Related]
14. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
[TBL] [Abstract] [Full Text] [Related]
15. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
[TBL] [Abstract] [Full Text] [Related]
16. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract] [Full Text] [Related]
17. Effects of hmga2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line.
Siahmansouri H; Somi MH; Babaloo Z; Baradaran B; Jadidi-Niaragh F; Atyabi F; Mohammadi H; Ahmadi M; Yousefi M
J Pharm Pharmacol; 2016 Sep; 68(9):1119-30. PubMed ID: 27350211
[TBL] [Abstract] [Full Text] [Related]
18. Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.
Negi LM; Jaggi M; Joshi V; Ronodip K; Talegaonkar S
Int J Biol Macromol; 2015 Feb; 73():222-35. PubMed ID: 25478964
[TBL] [Abstract] [Full Text] [Related]
19. Post-surgery morbidity and mortality in colorectal cancer in elderly subjects.
Savlovschi C; Serban D; Trotea T; Borcan R; Dumitrescu D
Chirurgia (Bucur); 2013; 108(2):177-9. PubMed ID: 23618565
[TBL] [Abstract] [Full Text] [Related]
20. Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models.
Wang L; Yao B; Li Q; Mei K; Xu JR; Li HX; Wang YS; Wen YJ; Wang XD; Yang HS; Li YH; Luo F; Wu Y; Liu YY; Yang L
Hum Gene Ther; 2011 Sep; 22(9):1061-9. PubMed ID: 21615297
[TBL] [Abstract] [Full Text] [Related]
[Next]
